At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. Our leadership in oncology extends more than 25 years and includes a range of therapies that have helped to transform the treatment landscape for previously underserved patient populations, in some cases shifting paradigms and becoming standard of care. We are building on our portfolio of approved medicines for hematologic cancers and solid tumors and advancing a cutting-edge pipeline focused on the power of innate immunity. We aim to introduce new classes of immunotherapies that can lead to deep, durable responses so that more patients can benefit from – and have access to – innovative medicines.
Takeda Oncology
Unlock to Claim this listing
Add / Modify Company
Click to rate this company
[Total: 0 Average: 0]
Click here to sign in to vote
4.1
Overall Excellence Rating
Industry
HealthcareCategory
Biotech & PharmaceuticalsESG/Ethical Impact
A healthier planet means healthier people. That’s why we act with urgency to minimize our environmental impact, developing sustainable solutions to improve public health and working with our peers and strategic partners to foster responsible innovation to protect the world in which we live.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.

Awards Received
2023
Revenues
$3,100,000,000.00
Website Traffic
Employee Rating
4.2
Customer Rating
3.8
Company Size
1000-5000
ESG Risk Rating
3
We’re Happy to Help.
Do you have questions about your ranking, our projects, or why you’re not on the list?